Cargando…
Upregulation of miR-138 Increases Sensitivity to Cisplatin in Hepatocellular Carcinoma by Regulating EZH2
Chemotherapeutic insensitivity is a major obstacle for effective treatment of hepatocellular carcinoma (HCC). Recently, new evidence showed that microRNAs (miRNAs) are closely related to drug sensitivity. This study aimed to investigate the relationship between miR-138 expression and cisplatin sensi...
Autores principales: | Zeng, Taohui, Luo, Lin, Huang, Yuye, Ye, Xiaoli, Lin, Jinhai |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7960019/ https://www.ncbi.nlm.nih.gov/pubmed/33748276 http://dx.doi.org/10.1155/2021/6665918 |
Ejemplares similares
-
MiR-138 Acts as a Tumor Suppressor by Targeting EZH2 and Enhances Cisplatin-Induced Apoptosis in Osteosarcoma Cells
por: Zhu, Ziqiang, et al.
Publicado: (2016) -
DNA methylation of miR-138 regulates cell proliferation and EMT in cervical cancer by targeting EZH2
por: Chen, Rui, et al.
Publicado: (2022) -
Silencing of miR-138-5p sensitizes bone anabolic action to mechanical stimuli
por: Chen, Zhihao, et al.
Publicado: (2020) -
MiR-138 induces cell cycle arrest by targeting cyclin D3 in hepatocellular carcinoma
por: Wang, Wen, et al.
Publicado: (2012) -
Circular RNA SAMD4A controls adipogenesis in obesity through the miR-138-5p/EZH2 axis
por: Liu, Yanjun, et al.
Publicado: (2020)